47 If BPC-157 ramps up EGR-1 in the wrong context, it could lead to overly aggressive tissue regrowth (like scar overgrowth or calcification in blood vessels)
No peer-reviewed clinical trials have evaluated the combined use of lipotropic injections and tirzepatide for weight management or metabolic outcomes
Is retatrutide a GLP-1 drug
CNS Drugs 26, 871882
Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million
Slow Recovery or Inflammation Is your body taking longer to bounce back from pain, stress, or physical activity